Cargando…

Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study

BACKGROUND: Gag-specific T lymphocytes play a key role in the control of human immunodeficiency virus (HIV) replication. Their restoration will be important for future reservoir targeting strategies. In this study, we aimed to identify immune correlates of Gag-specific CD8 T-cell proliferation in yo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warszawski, Josiane, Avettand-Fenoel, Véronique, Rouzioux, Christine, Scott-Algara, Daniel, Montange, Thomas, Didier, Céline, Le Chenadec, Jérôme, Viard, Jean-Paul, Dollfus, Catherine, Blanche, Stéphane, Buseyne, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414023/ https://www.ncbi.nlm.nih.gov/pubmed/28480237 http://dx.doi.org/10.1093/ofid/ofw239

Ejemplares similares

Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity — The ANRS-EP38-IMMIP Study
por: Le Chenadec, Jérôme, et al.
Publicado: (2015)

Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study
por: Frange, Pierre, et al.
Publicado: (2021)

Association between Prenatal Exposure to Antiretroviral Therapy and Birth Defects: An Analysis of the French Perinatal Cohort Study (ANRS CO1/CO11)
por: Sibiude, Jeanne, et al.
Publicado: (2014)

Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study
por: Mandelbrot, Laurent, et al.
Publicado: (2023)

Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
por: Delaugerre, Constance, et al.
Publicado: (2009)

A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level
por: Canouï, Etienne, et al.
Publicado: (2017)

CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory
por: Boufassa, Faroudy, et al.
Publicado: (2011)

Total HIV DNA: a global marker of HIV persistence
por: Rouzioux, Christine, et al.
Publicado: (2018)

Pro-viral DNA and antiretroviral treatment simplification
por: Zucman, D, et al.
Publicado: (2010)

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
por: Sáez-Cirión, Asier, et al.
Publicado: (2013)

Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
por: Plaçais, Léo, et al.
Publicado: (2021)

NKG2C(+) memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

Mycoplasma genitalium and Antimicrobial Resistance Among a Cohort of West African Men Who Have Sex With Men Using Preexposure Prophylaxis (CohMSM-PrEP ANRS 12369-Expertise France Study)
por: De Baetselier, Irith, et al.
Publicado: (2022)

Immunologic and Virologic Progression in HIV Controllers: The Role of Viral “Blips” and Immune Activation in the ANRS CO21 CODEX Study
por: Noel, Nicolas, et al.
Publicado: (2015)

P16-45. High avidity CD4+ T cell response directed to an immunodominant Gag epitope in HIV controllers: an ANRS EP36 study
por: Vingert, B, et al.
Publicado: (2009)

Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study
por: Dalmasso, Cyril, et al.
Publicado: (2008)

Metabolic risk factors in young adults infected with HIV since childhood compared with the general population
por: Arrive, Elise, et al.
Publicado: (2018)

Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection
por: Trémeaux, Pauline, et al.
Publicado: (2019)

Feasibility of Early Infant Diagnosis of HIV in Resource-Limited Settings: The ANRS 12140-PEDIACAM Study in Cameroon
por: Tejiokem, Mathurin C., et al.
Publicado: (2011)

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV
por: Hill, Kristi C, et al.
Publicado: (2022)

Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140—Pediacam study in Cameroon
por: Kfutwah, Anfumbom K. W., et al.
Publicado: (2017)

Hepatitis B Virus Prevalence and Vaccination in Men Who Have Sex With Men in West Africa (CohMSM ANRS 12324—Expertise France)
por: Dah, Ter Tiero Elias, et al.
Publicado: (2019)

Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV‐1 infection: results from a longitudinal study in the French ANRS Primo cohort
por: Novelli, Sophie, et al.
Publicado: (2020)

High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
por: Soumah, Abou Aissata, et al.
Publicado: (2022)

Latency, tropism and genetic variation of Simian Foamy Virus in blood and saliva from infected Humans
por: Rua, Réjane, et al.
Publicado: (2014)

A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort
por: Chaussade, Hélène, et al.
Publicado: (2020)

S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers
por: Descours, B, et al.
Publicado: (2009)

Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation
por: Wagner, Gabriel A, et al.
Publicado: (2023)

Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network
por: Spinelli, Matthew A, et al.
Publicado: (2019)

Early treated HIV-infected children remain at risk of growth retardation during the first five years of life: Results from the ANRS-PEDIACAM cohort in Cameroon
por: Sofeu, Casimir Ledoux, et al.
Publicado: (2019)

Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial
por: Sagaon-Teyssier, Luis, et al.
Publicado: (2016)

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
por: Fuchs, Jonathan D., et al.
Publicado: (2015)

Long-Term Virological Treatment Outcomes in Adolescents and Young Adults With Perinatally and Non-Perinatally Acquired Human Immunodeficiency Virus
por: Weijsenfeld, Annouschka M, et al.
Publicado: (2022)

HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses
por: Prazuck, Thierry, et al.
Publicado: (2013)

HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study
por: Breton, Guillaume, et al.
Publicado: (2022)

Plasma antibodies from humans infected with zoonotic simian foamy virus do not inhibit cell-to-cell transmission of the virus despite binding to the surface of infected cells
por: Couteaudier, Mathilde, et al.
Publicado: (2022)

Different factors associated with loss to follow-up of infants born to HIV-infected or uninfected mothers: observations from the ANRS 12140-PEDIACAM study in Cameroon
por: Sidze, Larissa Kamgue, et al.
Publicado: (2015)

Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon
por: Tagnouokam-Ngoupo, Paul Alain, et al.
Publicado: (2021)

Microalbuminuria in Perinatally HIV-Infected Children and Adolescents in the United States
por: Al Hammoud, Roukaya, et al.
Publicado: (2023)

Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care
por: Kamis, Kevin F, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uuc9nqm12tnqsrk2rtf9njds0j